Fujifilm Announces the Commercialization of Two Novel
CAD EYE is clinically demonstrated to increase adenoma detection rates and SCALE EYE is shown to improve accuracy and speed of measurement compared to...
Source: globenewswire.com
Page 8 - Trial Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Trial Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Trial Data Today - Breaking & Trending Today
ADVM Stock Price | Adverum Biotechnologies Inc. Stock Quote (U.S.: Nasdaq)
ADVM | Complete Adverum Biotechnologies Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Source: marketwatch.com
Global Drug Discovery Informatics Market Analysis Report 2023-2030 - by Workflow (Discovery Informatics, Biocontent Management), Services (Sequence Analysis Platform), Region and Segment Forecasts
/PRNewswire/ -- The "Global Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Workflow (Discovery Informatics, Biocontent Management),...
Source: prnewswire.com
GSK's cancer drug combination meets primary goal in late-stage trial
The results from the trial showed that Jemperli plus chemotherapy followed by Jemperli and Zejula improved progression-free survival, compared to chemotherapy alone in both the overall patient population and in a subpopulation of patients with certain types of tumours. Progression-free survival refers to how long a patient lives without the disease getting worse after treatment.
Source: yahoo.com
Semaglutide: The Drug of Today and a Steppingstone to Tomorrow
An overview of the journey and significant events of 2023 that have catapulted semaglutide from a type 2 diabetes agent to the topic of discussions among circles across healthcare and beyond.
Source: hcplive.com